Platelet-Rich Plasma Global Market to Grow Substantially at a CAGR of ~11% by 2028 | DelveInsight

Key Takeaways from the Platelet-Rich Plasma Market Report Key Takeaways from the Platelet-Rich Plasma Market Report To read more about the latest highlights related to the platelet-rich plasma market, get a snapshot of the key highlights entailed in theGlobal Platelet-Rich Plasma Market Report Platelet-Rich Plasma Overview Platelet-rich plasma (PRP) is obtained from blood. It is produced when human blood is spun down and platelet-rich plasma with platelet concentrations...

Key Takeaways from the Platelet-Rich Plasma Market Report

To read more about the latest highlights related to the platelet-rich plasma market, get a snapshot of the key highlights entailed in the Global Platelet-Rich Plasma Market Report

Platelet-Rich Plasma Overview

Platelet-rich plasma (PRP) is obtained from blood. It is produced when human blood is spun down and platelet-rich plasma with platelet concentrations above normal levels is isolated. Platelets aid in blood clotting as well as the repair of tendons, muscles, and ligaments. A normal platelet count is 150,000 to 450,000 platelets per microliter of blood. Platelet-rich plasma. Platelet-rich plasma is used in a variety of operations, including shoulder rotator cuff augmentation and tendon repair. Platelets are exceptionally high in healing agents and connective tissue growth.

Platelet-Rich Plasma Market Insights

North America accounted for the highest proportion of the platelet-rich plasma market in 2022, accounting for 43% of all regions. PRP demand is expected to rise during the forecast period due to factors such as an aging population, an increase in traumatic injuries caused by falls, accidents, and other causes, an increase in the number of orthopedic and cosmetic procedures, and recent product launches in the region. Furthermore, increased physician and patient awareness of newly established treatment processes and technologies are likely to contribute to the growth of the North America platelet-rich plasma market. Moreover, a high disposable income, advanced healthcare infrastructure, regulatory approval for new products, and a high level of knowledge regarding ophthalmic diseases all contributed to the success of the North American platelet-rich plasma market growth.

To know more about why North America is leading the market growth in the platelet-rich plasma market, get a snapshot of the Platelet-Rich Plasma Market Outlook 

Platelet-Rich Plasma Market Dynamics

The platelet-rich plasma market is seeing increased product demand due to a variety of factors, one of which is the increased prevalence of various therapeutic indications. PRP can successfully manage pain in orthopedic conditions and treat osteoporosis. As a result of the rising prevalence of orthopedic diseases such as arthritis, tennis elbow, golfer's elbow, plantar fasciitis, rotator cuff injuries, and others, the demand for PRP therapy will rise, as will the demand for PRP systems and kits used in PRP therapy.

Moreover, PRP therapy for fat grafts improves fat graft survival, reduces bruising and inflammation, and makes fat graft application easier. Furthermore, platelets-rich plasma is reported to accelerate healing by minimizing postoperative edoema and bleeding, making it useful in a variety of cosmetic operations. Thus, the increasing demand for platelet-rich plasma in various aesthetic operations such as cosmetic facials, facial rejuvenation, acne scars, facial scarring, facelift, and others will have a favorable impact on the platelet-rich plasma market in the approaching years.

Furthermore, PRP is extensively utilized for hair restoration in addition to facial surgeries. PRP can be used as a monotherapy or as an addition to conventional therapy or hair transplantation to treat hair loss, including androgenetic alopecia and female pattern hair loss.

However, the presence of alternative treatment choices, many sessions, resulting in high therapy costs, and other factors may limit the growth of the platelet-rich plasma market.

Additionally, during the COVID-19 pandemic, the platelet-rich plasma market was greatly impacted. The pandemic's spread resulted in the cancellation of outpatient consultations as well as the suspension of non-emergency hospitalization and treatment procedures for a variety of conditions such as orthopedic and sports injuries, gynecological, urological, cosmetic, and others. As a result, the number of individuals receiving standard therapy for the aforementioned illnesses has decreased. Furthermore, several elective procedures were postponed while the care of patients infected with coronavirus was prioritized.

Furthermore, supply chain, raw material, and other resource constraints interrupted device manufacturing, resulting in a shortage of devices and kits on the market. However, the invention of the COVID-19 vaccine triggered the economic recovery process. Furthermore, with the easing of lockdown restrictions and the return of normalcy in the economic landscape, the process of resumption of regular healthcare services such as outpatient visits for various treatments, therapies, and surgeries for the aforementioned ailments began, bringing the platelet-rich plasma market back on track.

Get a sneak peek at the platelet-rich plasma market dynamics @ Platelet-Rich Plasma Market Dynamics Analysis

Platelet-Rich Plasma Market Assessment

Which MedTech key players in the platelet-rich plasma market are set to emerge as the trendsetter explore @ Platelet-Rich Plasma Companies 

Table of Contents 

Related Reports

Psoriatic Arthritis Pipeline

Psoriatic Arthritis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key psoriatic arthritis companies, including Mylan, Celltrion, Pfizer, Amgen, among others.

Psoriatic Arthritis Market

Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psoriatic arthritis companies, including Mylan, Celltrion, Pfizer, Amgen, among others.

Psoriasis Pipeline

Psoriasis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key psoriasis companies, including Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, among others.

Psoriasis Market

Psoriasis Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key psoriasis companies, including Mylan, Biocad, Bristol-Myers Squibb, Celltrion, Coherus BioSciences, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us
Shruti Thakur  
info@delveinsight.com  
+1(919)321-6187
https://www.delveinsight.com/medical-devices 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg 

 

View original content:https://www.prnewswire.co.uk/news-releases/platelet-rich-plasma-global-market-to-grow-substantially-at-a-cagr-of-11-by-2028--delveinsight-301863907.html